Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2022

Mar 2, 2022

35221_dirs_2022-03-01_5bfa2048-90e7-4973-baa9-b04bb1778e8e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2021-06-15

Reporting Person: Baxter Timothy E (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-15 Employee stock option (right to buy) $5.79 A 75000 Acquired 2031-06-15 Common stock (75000) Direct

Footnotes

F1: The option vests in 12 quarterly installments, commencing on June 30, 2021.